• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,112.15 -206.24
( -0.27%)
Global Indices
Nasdaq
50,030.26 645.37
(1.31%)
Dow Jones
7,453.29 78.68
(1.07%)
Hang Seng
61,747.25 1,942.84
(3.25%)
Nikkei 225
10,425.97 95.42
(0.92%)
Forex
USD-INR
96.52 0.30
(0.32%)
EUR-INR
112.16 0.19
(0.17%)
GBP-INR
129.37 0.68
(0.52%)
JPY-INR
0.61 0.00
(0.22%)

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532989
INE878I01022
38.5638498
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BAFNAPH
28.6
327.4
EPS(TTM)
Face Value()
Div & Yield %
4.84
10
0
 

As on: May 21, 2026 01:19 PM



Particulars
Company Name Bafna Pharmaceuticals Ltd
Face Value 10
BSE Code 532989
Year End 202503
Full Year
Equity ( in Cr.) 23.66
B.V. 38.60
Sales in Cr. 145.86
NP in Cr. 6.37
NP Var% -12.00
Div% 0.00
CPS 4.80
EPS 2.70
Traded Value( in Lakhs) 0.14
52 Week High 205.00
52 Week Low 72.00
Price BSE 138.00
Price NSE 138.00
Market Capital( in Cr.) 327.40
P/C Ratio 29.00
P/E Ratio 51.20
Price Vs.BV 3.58
Latest Quarter
Year End 202512
Sales in Cr. 38.29
NP in Cr. 1.84
NP Var % 91.00
Trailing Twelve Months
Year End 202512
Sales 143.45
OPM 5.06
NP 0.75
NP Var% 146.04
EPS 4.84
PE 28.60